SS
PDSB icon

SBI Securities’s PDS Biotechnology PDSB Stock Holding History

SBI Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71 Buy
118
+9
+8% +$7 ﹤0.01% 3500
2025
Q4 		$84 Sell
109
-1
-0.9% -$1 ﹤0.01% 3460
2025
Q3 		$111 Sell
110
-97
-47% -$114 ﹤0.01% 3488
2025
Q2 		$275 Buy
207
+101
+95% +$137 ﹤0.01% 3207
2025
Q1 		$126 Hold
106
– – ﹤0.01% 3375
2024
Q4 		$173 Buy
+106
New +$281 ﹤0.01% 3291

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBI Securities's PDSB Position: Q1 2026 in Review

SBI Securities increased its PDS Biotechnology (PDSB) stake by 8.3% in Q1 2026, buying an estimated $7 and bringing the position to 118 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #3500.

SBI Securities first reported a position in PDSB in Q4 2024 and has held it in 6 quarters since. The position peaked at $275 in Q2 2025. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • SBI Securities held 118 shares of PDS Biotechnology worth $71 as of Q1 2026.
  • SBI Securities bought 9 PDS Biotechnology shares in Q1 2026, an estimated $7.
  • PDS Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3500 holding.
  • SBI Securities first reported a position in PDS Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's PDS Biotechnology position peaked at $275 in Q2 2025.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.